Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhancing endonuclease based gene editing in primary cells

Enhancing endonuclease based gene editing in primary cells

US Patent 10563226 · Granted Feb 18, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vivo gene therapy using intraosseous delivery of a lentiviralgene construct2025
Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell select2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2025
Coupling endonucleases with end-processing enzymes drives high efficiency gene d2025
Methods of exogenous drug activation of chemical-induced signaling complexes exp2025
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labe2025
Methods of use for CAR T cells2025
Optimized mRNA encoding CAS9 for use in LNPs2025
Production of engineered T-cells by sleeping beauty transposon coupled with meth2025
Sequencing method for CAR T cell therapy2025